GLP-1 agonists
‘GLP-1s for Everything!’: Balancing Access With Sustainability
Glucagon-like peptide-1 receptor agonists are moving far beyond their established uses for managing type 2 diabetes ...
AUGUST 16, 2025
GLP-1s Slay Yet Another Condition: Acute Pancreatitis
In a study presented at DDW 2025, GLP-1s appeared to protect patients with chronic pancreatitis from developing ...
AUGUST 15, 2025
Insurance Restrictions, Low Reimbursement Hitting Pharmacies on GLP-1s
Despite increasing demand for GLP-1 drugs, these medications are often excluded from coverage in employer health ...
MAY 27, 2025
Most Patients Can Safely Remain on GLP-1s Before Surgery
Most patients can continue taking GLP-1 receptor agonists before undergoing elective surgery, according to new ...
APRIL 27, 2025
‘A Billion-Dollar Question’ Emerges in GLP-1 Legal Fight
Eli Lilly has sued the FDA over the classification of its investigational GLP-1 drug, retatrutide, arguing that the ...
APRIL 22, 2025
GLP-1 Compounding: Expect Inspections
503A compounding pharmacies can expect more inspections from their state boards of pharmacy and audits from PBMs ...
MARCH 14, 2025
New Legal Weapons Against GLP-1 Compounders Emerge
GLP-1 manufacturers are aggressively pursuing multiple legal and regulatory strategies to stop compounding of the ...
MARCH 6, 2025
EHR Data Guide Preoperative Pausing of GLP-1 Agonists and SGLT2 Inhibitors
GLP-1 agonists and SGLT2 inhibitors should be temporarily withheld prior to elective surgery to avoid ...
MARCH 1, 2025
GLP-1 Compounding: Expect Inspections
503A compounding pharmacies can expect more inspections from their state boards of pharmacy and audits from PBMs ...
FEBRUARY 13, 2025
Zepbound Approved for Obstructive Sleep Apnea
The FDA approved tirzepatide (Zepbound, Eli Lilly) as the first prescription medicine for adults with ...
DECEMBER 20, 2024
FDA Declares End to Tirzepatide Shortage
The FDA has officially removed tirzepatide from its drug shortage list, meaning that compounding pharmacies will no ...
DECEMBER 20, 2024
GLP-1 ‘Shadow System’ Of Internet Sellers Poses A Major Safety Concern
Dozens of unscrupulous web-based sellers of glucagon-like peptide-1 agonists are evading FDA scrutiny and patient ...
DECEMBER 16, 2024
